Lipocine Inc. (LPCN) — 10-Q Filings

10-Q Filings (7)

• 10-Q Filing — May 7, 2026
• Lipocine's Q3 Loss Widens Amidst Plummeting License Revenue — Nov 6, 2025 Risk: high
  Lipocine Inc. (LPCN) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $7,257,421, a substantial rise from the
• Lipocine Narrows Q2 Loss Amidst Zero Revenue — Aug 5, 2025 Risk: high
  Lipocine Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net loss for the three
• Lipocine Inc. Files Q1 2025 10-Q Report — May 8, 2025 Risk: medium
  Lipocine Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations. Speci
• Lipocine Inc. Files Q3 2024 10-Q Report — Nov 7, 2024 Risk: medium
  Lipocine Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and operational updates for the th
• Lipocine Inc. Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Lipocine Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers financial performance and operational updates for the second quarter of 2024
• Lipocine Inc. Files 10-Q for Q1 2024 — May 9, 2024 Risk: low
  Lipocine Inc. (LPCN) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Lipocine Inc. reported its Q1 2024 financial results on May 9, 2024. The filin

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX